Cargando…
Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial
BACKGROUND: BCG vaccine may reduce overall mortality by increasing resistance to nontuberculosis infections. In 2 randomized trials in Guinea-Bissau of early BCG-Denmark (Statens Serum Institut) given to low-weight (LW) neonates (<2500 g at inclusion) to reduce infant mortality rates, we observed...
Autores principales: | Biering-Sørensen, Sofie, Aaby, Peter, Lund, Najaaraq, Monteiro, Ivan, Jensen, Kristoffer Jarlov, Eriksen, Helle Brander, Schaltz-Buchholzer, Frederik, Jørgensen, Anne Sofie Pinstrup, Rodrigues, Amabelia, Fisker, Ane Bærent, Benn, Christine Stabell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849087/ https://www.ncbi.nlm.nih.gov/pubmed/29579158 http://dx.doi.org/10.1093/cid/cix525 |
Ejemplares similares
-
National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials
por: Andersen, Andreas, et al.
Publicado: (2018) -
BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study
por: Thysen, Sanne Marie, et al.
Publicado: (2014) -
Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials
por: Biering-Sørensen, Sofie, et al.
Publicado: (2018) -
On the investigation of non-specific effects of BCG: Interpreting global vaccine data
por: Fisker, Ane Bærent, et al.
Publicado: (2021) -
The Effect of 50 000 IU Vitamin A with BCG Vaccine at Birth on Growth in the First Year of Life
por: Fisker, Ane Bærent, et al.
Publicado: (2011)